How Moderna’s Vaccine Works – The New York Times
Moderna, a Massachusetts-based vaccine developer, partnered with the National Institutes of Health to develop and test a coronavirus vaccine known as mRNA-1273. A clinical trial demonstrated that the vaccine has an efficacy rate of 94.1 percent in preventing Covid-19.
